Home > M&A deals 2001 > Glaxosmithkline plc acquires Block Drug Company, Inc.
Add-on Acquistion · Life Science · January 2001

Glaxosmithkline plc acquires Block Drug Company, Inc.

On January 16, 2001, Glaxosmithkline plc acquired Block Drug Company, Inc., a life science company in New Jersey, United States.

Deal at a glance

AnnouncedJanuary 16, 2001 TypeAdd-on Acquistion TargetBlock Drug Company, Inc. Buyer Glaxosmithkline plc SectorLife Science LocationNew Jersey, United States ValueMembers only

Target company

Block Drug Company, Inc.
New Jersey, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Glaxosmithkline plc
Company · 84 deals on record
  • 3rd transaction in life science
  • 5th transaction in United States
84deals, all time
57in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Affinivax, Inc.Same lead buyer · May 2022
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Block Drug Company, Inc.?Glaxosmithkline plc acquired Block Drug Company, Inc. on January 16, 2001.

What type of deal was it?It was a add-on acquistion in the life science sector in 2001.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).